• Marinus Pharmaceuticals, Inc. will participate in a fireside chat at the 2024 Cantor Global Healthcare Conference on September 19, 2024, at 10:20 a.m.
• The company is dedicated to developing innovative therapeutics to treat seizure disorders.
• A link to the event can be accessed on the Investors and Media page of Marinus’ website.
• The webcast will be available approximately two hours after the completion of the event and.
RADNOR, Pa. / Sep 10, 2024 / Business Wire / Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that management will participate in a fireside chat at the 2024 Cantor Global Healthcare Conference on Thursday, September 19, 2024, at 10:20 a.m. ET.
A link to the event can be accessed on the Investors and Media page of Marinus’ website at ir.marinuspharma.com/events-and-presentations. A replay of the webcast will be available approximately two hours after the completion of the event and will be archived for up to 90 days.
About Marinus Pharmaceuticals
Marinus is a commercial-stage pharmaceutical company dedicated to the development of innovative therapeutics for seizure disorders. The Company’s product, ZTALMY® (ganaxolone) oral suspension CV, is an FDA-approved prescription medication introduced in the U.S. in 2022. For more information, please visit www.marinuspharma.com and follow us on Facebook, LinkedIn and X.
| Last Trade: | US$1.84 |
| Daily Change: | 0.11 6.36 |
| Daily Volume: | 567,709 |
| Market Cap: | US$101.350M |
September 20, 2024 August 19, 2024 August 13, 2024 June 17, 2024 | |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORE
